At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 5, 2026 at 13:24 ET
FMR LLC (Fidelity) filed an amended Schedule 13G disclosing beneficial ownership of 2,565,828 shares of Praxis Precision Medicines common stock as of September 30, 2026, representing 9.2% of outstanding shares. This is a routine passive stake update with no change in investment intent.
- FMR LLC reported beneficial ownership of 2,565,828 shares of Praxis Precision Medicines common stock as of September 30, 2026
- The stake represents 9.2% of outstanding shares
- Filing is an amendment to Schedule 13G, indicating passive investment intent
- FMR LLC subsidiaries FIAM LLC, Fidelity Management & Research Company LLC, and Strategic Advisers LLC are among the reporting entities
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access